New Study Reveals U.S. Businesses Average Over 5 Major Outages Annually, with 63% Occurring During Critical Peak Trading Times
Philadelphia, PA and Boston, MA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- A ne......
Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients
Ingelheim, Germany– 12 January, 2026 – Boehringer Ingelheim today announced a strat......